EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Luteal phase support for patients undergoing frozen-thawed embryo transfer cycles--the required progesterone dose



Luteal phase support for patients undergoing frozen-thawed embryo transfer cycles--the required progesterone dose



Clinical and Experimental Obstetrics & Gynecology 34(1): 25-26



With the recent trend toward single-embryo transfer (ET), cryopreservation of extraneous embryos is becoming increasingly prevalent. Several replacement protocols for frozen-thawed ET exist, with no consensus regarding the dosage or delivery mode of progesterone. Hormonal replacement with only estrogen and progesterone is the most frequently used protocol in women with and without functioning ovaries in our unit. Since August 2005, we have doubled the usual daily dose of progesterone for luteal support due to a high prevalence of patients experiencing withdrawal bleeding 11-13 days after ET. We compared the outcome of frozen-thawed ET cycles using different doses of progesterone for luteal support. While the prevalence of embryos that survived the thawing process was significantly higher in the earlier (69%) as compared to the later period (58%), positive b-hCG pregnancy rates (17.5% vs 44.8%, respectively) and clinical pregnancy rates per transfer (7.9% vs 41.4%, respectively) were significantly higher in the later period. We conclude that high-dose progesterone supplementation in the luteal phase of frozen-thawed ET cycles results in a significantly higher clinical pregnancy rate.

(PDF emailed within 1 workday: $29.90)

Accession: 054198835

Download citation: RISBibTeXText

PMID: 17447632



Related references

The effect of luteal phase progesterone supplementation on natural frozen-thawed embryo transfer cycles. Obstetrics & Gynecology Science 57(4): 291-296, 2014

Comparison of four protocols for luteal phase support in frozen-thawed Embryo transfer cycles: a randomized clinical trial. Archives of Gynecology and Obstetrics (): -, 2016

Effects of single dose GnRH agonist as luteal support on pregnancy outcome in frozen-thawed embryo transfer cycles: an RCT. Iranian Journal of Reproductive Medicine 13(8): 483-488, 2015

Luteal phase support for frozen embryo transfer cycles: intramuscular or vaginal progesterone?. Fertility and Sterility 101(3): 627-628, 2014

Crinone Gel for Luteal Phase Support in Frozen-Thawed Embryo Transfer Cycles: A Prospective Randomized Clinical Trial in the Chinese Population. Plos One 10(7): E0133027-E0133027, 2016

A comparison of luteal phase support in graduated estradiol/progesterone replacement cycles using intramuscular progesterone alone vs combination with vaginal suppositories on outcome following frozen embryo transfer. Fertility & Sterility 81(Suppl 3): S30, April, 2004

A comparison of luteal phase support in graduated estradiol/progesterone replacement cycles using intramuscular progesterone alone versus combination with vaginal suppositories on outcome following frozen embryo transfer. Clinical and Experimental Obstetrics & Gynecology 32(2): 93-94, 2005

Phase III trial of 8% vaginal progesterone gel for luteal phase support in Japanese women undergoing in vitro fertilization and fresh embryo transfer cycles. Reproductive Medicine and Biology 16(1): 52-57, 2017

Phase III trial of 8% vaginal progesterone gel for luteal phase support in Japanese women undergoing in vitro fertilization and fresh embryo transfer cycles. Reproductive Medicine and Biology 16(1): 52-57, 2017

Impact of different luteal support methods on clinical outcomes of frozen-thawed embryo transfer cycles. Zhonghua Yi Xue Za Zhi 94(41): 3256-3258, 2015

Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles. Fertility and Sterility 101(1): 105-111, 2014

Administration of a GnRH agonist during the luteal phase frozen-thawed embryo transfer cycles: a meta-analysis. Gynecological Endocrinology 1-5, 2018

Mid-luteal phase gonadotropin-releasing hormone agonist support in frozen-thawed embryo transfers during artificial cycles: A prospective interventional pilot study. Journal of Gynecology Obstetrics and Human Reproduction 47(8): 391-395, 2018

Effectiveness of high-dose transvaginal progesterone supplementation for women who are undergoing a frozen-thawed embryo transfer. Reproductive Medicine and Biology 17(3): 242-248, 2018

Luteal phase support does not improve the clinical pregnancy rate of natural cycle frozen-thawed embryo transfer: a retrospective analysis. European Journal of Obstetrics, Gynecology, and Reproductive Biology 169(1): 50-53, 2014